Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00951665 |
|---|---|
| Brief Title: | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer |
| First Submitted : | August 3, 2009 |
| First Submitted that Met QC Criteria : | August 3, 2009 |
| First Posted : | August 4, 2009 (Estimate) |
| Results First Submitted : | January 4, 2016 |
| Results First Submitted that Met QC Criteria : | May 17, 2016 |
| Results First Posted : | June 24, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 17, 2016 |
| Last Update Posted : | June 24, 2016 (Estimate) |